Patients' subjective rating of mental health improvement in a randomised controlled trial.

Karen P Hayhurst; Richard J Drake; Jennifer A Massie; Graham Dunn; Shôn W Lewis

doi:10.1016/j.psychres.2015.07.038

Patients' subjective rating of mental health improvement in a randomised controlled trial.

Karen P Hayhurst, Richard J Drake, Jennifer A Massie, Graham Dunn, Shôn W Lewis

Research output: Contribution to journal › Article › peer-review

Abstract

We used UK CUtLASS RCT data to establish that patients' rating of mental health improvement (baseline to week 12) correlated significantly with percentage symptom improvement (PANSS). In a regression analysis predictors of the patient's week 12 mental health rating were percentage change in positive symptoms (PANSS), DAI score and the patient's rating of side effects. Patients in an RCT were able to subjectively rate their mental health status, validated by objective improvement on the PANSS.

Original language	English
Pages (from-to)	593-595
Number of pages	2
Journal	Psychiatry Research
Volume	229
Issue number	1-2
DOIs	https://doi.org/10.1016/j.psychres.2015.07.038
Publication status	Published - 30 Sept 2015

Keywords

Antipsychotic
Assessment
Schizophrenia

Access to Document

10.1016/j.psychres.2015.07.038

1 Meeting Abstract

Patients’ subjective rating of mental health improvement on clozapine [Abstract]
Hayhurst, K. P. & Lewis, S. W., 2004, In: Schizophrenia Research. 67, 1, p. 226-227 2 p.
Research output: Contribution to journal › Meeting Abstract

1 Participating in a conference, workshop, exhibition, performance, inquiry, course etc

12th Biennial Winter Workshop on Schizophrenia
Hayhurst, K. (Poster presenter)
Feb 2004
Activity: Participating in or organising event(s) › Participating in a conference, workshop, exhibition, performance, inquiry, course etc › Research

Cite this

@article{d22a9ce44c554dfbb2e3615987589ff1,

title = "Patients' subjective rating of mental health improvement in a randomised controlled trial.",

abstract = "We used UK CUtLASS RCT data to establish that patients' rating of mental health improvement (baseline to week 12) correlated significantly with percentage symptom improvement (PANSS). In a regression analysis predictors of the patient's week 12 mental health rating were percentage change in positive symptoms (PANSS), DAI score and the patient's rating of side effects. Patients in an RCT were able to subjectively rate their mental health status, validated by objective improvement on the PANSS.",

keywords = "Antipsychotic, Assessment, Schizophrenia",

author = "Hayhurst, {Karen P} and Drake, {Richard J} and Massie, {Jennifer A} and Graham Dunn and Lewis, {Sh{\^o}n W}",

year = "2015",

month = sep,

day = "30",

doi = "10.1016/j.psychres.2015.07.038",

language = "English",

volume = "229",

pages = "593--595",

journal = "Psychiatry Research",

issn = "1872-7123",

publisher = "Elsevier BV",

number = "1-2",

}

TY - JOUR

T1 - Patients' subjective rating of mental health improvement in a randomised controlled trial.

AU - Hayhurst, Karen P

AU - Drake, Richard J

AU - Massie, Jennifer A

AU - Dunn, Graham

AU - Lewis, Shôn W

PY - 2015/9/30

Y1 - 2015/9/30

N2 - We used UK CUtLASS RCT data to establish that patients' rating of mental health improvement (baseline to week 12) correlated significantly with percentage symptom improvement (PANSS). In a regression analysis predictors of the patient's week 12 mental health rating were percentage change in positive symptoms (PANSS), DAI score and the patient's rating of side effects. Patients in an RCT were able to subjectively rate their mental health status, validated by objective improvement on the PANSS.

AB - We used UK CUtLASS RCT data to establish that patients' rating of mental health improvement (baseline to week 12) correlated significantly with percentage symptom improvement (PANSS). In a regression analysis predictors of the patient's week 12 mental health rating were percentage change in positive symptoms (PANSS), DAI score and the patient's rating of side effects. Patients in an RCT were able to subjectively rate their mental health status, validated by objective improvement on the PANSS.

KW - Antipsychotic

KW - Assessment

KW - Schizophrenia

U2 - 10.1016/j.psychres.2015.07.038

DO - 10.1016/j.psychres.2015.07.038

M3 - Article

C2 - 26208989

SN - 1872-7123

VL - 229

SP - 593

EP - 595

JO - Psychiatry Research

JF - Psychiatry Research

IS - 1-2

ER -

Patients' subjective rating of mental health improvement in a randomised controlled trial.

Abstract

Keywords

Access to Document

Fingerprint

Research output

Patients’ subjective rating of mental health improvement on clozapine [Abstract]

Activities

12th Biennial Winter Workshop on Schizophrenia

Cite this